Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03396926
Title Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.